No Data
De Shi-B hit a record high.
Gelonghui reported on May 6th that De Shi-B (02526.HK) rose by 1.72%, closing at HKD 343.8, setting a new all-time high for its stock price. The company's total market capitalization now stands at HKD 30.557 billion.
Hong Kong Stock Market Midday Review | Hang Seng Index rose 1.7% in the morning session, Xiaomi Group surged over 8%.
Xiaomi Group-W (01810) surged over 8%, with Xiaomi Auto's April deliveries exceeding 30,000 units, and the new generation SU7 securing over 70,000 orders.
H-share Movement | Deshi-B (02526) Surged Over 15% to Reach a New High Since Listing as Deshi Unveiled its Self-developed iMedImage Medical Imaging Foundation Large Model at the Canton Fair
De Shi-B (02526) surged over 15% in the morning session, hitting a record high of 335 Hong Kong dollars since its listing, marking an increase of nearly 240% from its IPO price of 99 Hong Kong dollars. As of the time of writing, it was up 11.81%, trading at 322 Hong Kong dollars, with a turnover of 37.3822 million Hong Kong dollars.
Diagens Biotechnology's 2025 Loss Widens
Enable Medical AI to "Think Like a Doctor" – Deshi Releases Global Medical Large Model Evaluation Platform DoctorBench
On April 30, Hangzhou Desheng Biotechnology Co., Ltd. (2526.HK, referred to as "Desheng") officially launched the medical AI evaluation platform DoctorBench in Hong Kong and unveiled the first global ranking of large medical models. WiseDiag-v2 by Hangzhou Zhizhen Technology, Gemini-3.1-Pro-Preview by Google, and GPT-5.4 by OpenAI ranked in the top three. The platform, for the first time, uses "clinical practical capabilities" as the core benchmark, establishing a multidimensional evaluation system that closely mirrors real-world diagnostic and treatment scenarios for global large medical models. Currently,
Press Release: Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine